IMPL Market Cap History Table | ||||||||||||||||||||||||
Also see: IMPL Shares Outstanding History and IMPL YTD Return |
IMPL Market Cap History Table | ||||||||||||||||||||||||
Also see: IMPL Shares Outstanding History and IMPL YTD Return |
IMPL Market Cap History Chart | |||||||||||||||||||||||||||||||||
-78.01% CAGR Mouse over chart for data details
|
IMPL Stock Price Chart |
About Impel Pharmaceuticals Inc |
Impel Pharmaceuticals is a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with unmet medical needs, with an initial focus on the Central Nervous System. Co. has launched Trudhesa for the acute treatment of migraine headaches with or without aura in adult patients. Co. is developing several product candidates, including INP105 for the acute treatment of agitation and aggression in patients with Autism Spectrum Disorder. Co.'s pipeline of proprietary product candidates also includes INP107 for the treatment of OFF episodes in Parkinson's Disease. We show 11 historical shares outstanding datapoints in our IMPL shares outstanding history coverage, used to compute IMPL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IMPL market cap history over the course of time is important for investors interested in comparing IMPL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IMPL versus a peer is one thing; comparing IMPL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IMPL can fluctuate over the course of history. With this page we aim to empower investors researching IMPL by allowing them to research the IMPL market cap history. |
IMPL Current Stock Quote |
Free IMPL Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
IMPL Share Performance |
Market Cap Peers |
Impel NeuroPharma (IMPL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
IMRA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.